04:02 PM EST, 01/10/2025 (MT Newswires) -- (Updates with response from Eli Lilly ( LLY ) in the last paragraph.)

Eli Lilly ( LLY ) is nearing a deal to acquire privately held Scorpion Therapeutics, valuing the Boston-based company working on potential cancer treatments at around $2.5 billion, according to the Financial Times, citing sources.

A deal could be announced in coming days, the sources told the newspaper.

Lilly declined to comment to MT Newswires, while Scorpion Therapeutics did not immediately respond.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 799.46, Change: +12.24, Percent Change: +1.55